Back to companies
Niagen Bioscience, Inc.
NAGEUSNASDAQPharmaceuticals & HealthcareNiagen Bioscience, Inc.
Revenue
$129.4mn
YoY +29.9%
Operating income
$16.3mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API